The FDA has granted accelerated approval to Merus’ Bizengri in the treatment of advanced, unresectable NG1+ lung and pancreatic cancers.

Adaptive Research and WRO have partnered to expand access to cancer treatment studies for individuals in the San Francisco Bay Area.

The uncertainty and fears following the US Supreme Court’s decision to overturn Roe vs Wade have been heightened after Trump’s election win.

Teva has reported positive outcomes from its Phase III SPACE trial of Ajovy for episodic migraine in young individuals aged six to 17 years.

Vaxcyte has commenced the Phase II trial of its 31-valent pneumococcal conjugate vaccine (PCV) candidate, VAX-31, in healthy infants.

Speaking at the Clinical Trials in Oncology conference in Munich, GlobalData’s Ophelia Chan broke down how many real world data saves trials.

An open-label Phase III trial showed that participants using Zepbound saw 47% greater relative weight loss compared to Wegovy.

Clinical Trials in Oncology conference a panel urged trial designers to be considerate of what they are asking from patients.

Vivavision’s non-steroidal immunomodulator met the primary endpoint in a Phase II trial as a post-op inflammation treatment after cataract surgery.

GlobalData epidemiologists project that 12-month total prevalent cases of alcohol use disorder (AUD) in Mexico will rise to 2,420,000 by 2028.

Clinical Trials in Oncology conference, healthcare companies were urged to keep rigorous records during clinical trials.

Arrowhead Pharmaceuticals has sent an application to the New Zealand regulator seeking clearance to commence a Phase I/IIa trial of ARO-ALK7.